These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14964447)

  • 21. Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry.
    Chung L; Baxter RC
    Growth Horm IGF Res; 2009 Aug; 19(4):383-7. PubMed ID: 19467616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of human growth hormone doping in urine: out of competition tests are necessary.
    Saugy M; Cardis C; Schweizer C; Veuthey JL; Rivier L
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):201-11. PubMed ID: 9001966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect evidence of hormone abuse. Proof of doping?
    Minuto F; Barreca A; Melioli G
    J Endocrinol Invest; 2003 Sep; 26(9):919-23. PubMed ID: 14964446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential parameters for the detection of hGH doping.
    Kniess A; Ziegler E; Kratzsch J; Thieme D; Müller RK
    Anal Bioanal Chem; 2003 Jul; 376(5):696-700. PubMed ID: 12750868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports.
    Voss SC; Giraud S; Alsayrafi M; Bourdon PC; Schumacher YO; Saugy M; Robinson N
    Growth Horm IGF Res; 2013 Aug; 23(4):105-8. PubMed ID: 23608056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GH & IGF Research issue on doping with growth hormone.
    Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
    [No Abstract]   [Full Text] [Related]  

  • 29. Detecting growth hormone abuse in athletes.
    Holt RI
    Anal Bioanal Chem; 2011 Aug; 401(2):449-62. PubMed ID: 21590497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A robust test for growth hormone doping--present status and future prospects.
    Nelson AE; Ho KK
    Asian J Androl; 2008 May; 10(3):416-25. PubMed ID: 18385903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors.
    Okano M; Nishitani Y; Sato M; Kageyama S
    Drug Test Anal; 2012 Sep; 4(9):692-700. PubMed ID: 22733714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moving one step closer to catching the GH cheats: The GH-2004 experience.
    Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
    Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report on an anti-doping operation in Guadeloupe: High number of positive cases and inferences about doping habits.
    Marchand A; Buisson C; Martin L; Martin JA; Molina A; Ressiot D
    Drug Test Anal; 2017 Nov; 9(11-12):1753-1761. PubMed ID: 28296276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD
    Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment and immunoprecipitation of 22 kDa human growth hormone spiked into human urine.
    Bane TK; Timmons MS; Kauffman SJ; Catlin DH
    Drug Test Anal; 2009 Sep; 1(9-10):441-6. PubMed ID: 20355229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
    Young RR; Bielak JS; Horvitz SL
    Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
    Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
    Kniess A; Ziegler E; Thieme D; Müller RK
    J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.